- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03160560
Controlling Oral Malodor by ClōSYS® Oral Rinse
Efficacy of ClōSYS® Oral Rinse Products in Human Subjects in Controlling Oral Malodor
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Design:
The products used in the study are: ClōSYS Alcohol-Free Oral Rinse (also referred as ClōSYS Unflavored Oral Rinse) and ClōSYS justRIGHT MILD MINT Oral Rinse (also referred as ClōSYS Flavored Oral Rinse or Gentle Mint Flavored Oral Rinse). This is an in-vivo, eight-week, a single-center, randomized, double-blind (subject/investigator), 2-way cross-over design clinical study. There are two independent groups. Each subject of each group gets crossed over to the other sub-group within a same group after the washout period. Each group has their own control group. In the first phase, 25 subjects (50%) of each group are randomly assigned to the active group; the other 25 subjects are assigned to the control group. In the second phase, the participants will be crossed over within sub-group assignment. The Study enrolled 100 subjects, aged 21 to 65 years, with a slight to strong intrinsic oral malodor, as determined by a panel of trained odor judges calibrated and standardized using a range of standard odorants sufficient to reflect the different patterns of nose receptors.
Study Plan:
Subjects will receive verbal and written oral hygiene instructions, and either one bottle (16 oz. each) of ClōSYS Unflavored Oral Rinse, ClōSYS Flavored Oral Rinse- or Placebo Oral Rinse each week. Subjects will also receive measuring cups for dispensing the rinse and a diary log for recording usage (the Oral Hygiene Kit) for use during the treatment. After a 2-week wash out period, each subject will receive another bottle of oral rinse according to their group assignment.
Subjects will be instructed to rinse twice a day, each in the morning and in the evening, with 15 mL mouth rinse for 30 seconds. They will note in their patient's log the date and time of rinsing.
Subjects will be instructed to continue with their normal oral hygiene practices, including tooth brushing but omitting any use of oral rinses or mouthwashes except for the Study materials. The subjects also will be instructed not to use other non-study related products such as breath mints, lozenge, gums, etc. as well as refraining from elective dental procedures during the study period.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Completion of the Informed Consent.
- Must be able to follow verbal/written instructions.
- Between 21 to 65 years of age, male or female.
- Has normal oral interior cheek wall tissues.
- In good general health.
- Should not have any severe or debilitating disease that may impede participation.
- Average organoleptic intensity rating of at >2.6 but <4.5 on an intensity scale of 0-5.
Exclusion Criteria:
- Pregnant or nursing.
- Diagnosis of Xerostomia, including medication induced Xerostomia.
- Oral or extraoral piercing that interferes with the clinical assessments in the mouth.
- Fixed or removable oral appliance.
- Advanced periodontal disease or excessive gingival recession.
- Known allergy or sensitivity to study products.
- Unwilling to abstain from all oral hygiene products other than those prescribed for the study.
- Heavy deposits of calculus, either supragingival and/or subgingival.
- History of severe transmittable infectious disease e.g. hepatitis, HIV, tuberculosis.
- Medical or dental condition that would be unduly affected by participation in this study.
- Any other condition that may interfere with the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Test-Unflavored Rinse
CloSYS Oral Rinse product containing 0.1% stabilized chlorine dioxide (sodium chlorite) in aqueous solution.
|
Subjects in Test group will receive ClōSYS® Unflavored Rinse.
Other Names:
|
Active Comparator: Test-Flavored Rinse
CloSYS Oral Rinse product containing 0.1% stabilized chlorine dioxide (sodium chlorite) in aqueous solution with mint flavoring.
|
Subjects in Test group will receive ClōSYS® Flavored Rinse.
Other Names:
|
Placebo Comparator: Placebo
CloSYS Oral Rinse product (no chlorine dioxide)
|
Subjects in Placebo group will receive Placebo Rinse.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Malodor as Measured by Organoleptic Score
Time Frame: At baseline and weekly for 3 weeks for each condition and cross-over
|
A 6-level organoleptic score from 0 - 5 will be used.
Score of 0 indicating malodor cannot be detected and score of 5 indicating very strong malodor.
Breath scores were compared to baseline with malodor intensity reduction recorded as negative.
|
At baseline and weekly for 3 weeks for each condition and cross-over
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Yiming Li, DDS MSD PhD, Center for Dental Research, Loma Linda University School of Dentistry
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- LLUSD-RPR-Malodor-ADA-2016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oral Malodor
-
Novozymes A/SCompletedOral MalodorUnited States
-
Rowpar Pharmaceuticals, Inc.University Health Resources GroupCompletedOral Malodor
-
Procter and GambleCompletedOral MalodorUnited States
-
Riyadh Colleges of Dentistry and PharmacyCompleted
-
Hadassah Medical OrganizationCompletedHalitosis | Bad Breath | Oral MalodorIsrael
-
Hadassah Medical OrganizationCompleted
-
Fernanda Muñoz SepúlvedaSubvención Presidencial, Ministerio de Hacienda, Chile; Centro Interuniversitario... and other collaboratorsCompletedOral Health Knowledge | Oral Health Attitudes | Oral Health Self-efficacyChile
-
Lund University HospitalEnrolling by invitationMandibular Reconstruction | Oral Surgical Procedures | Surgery, OralSweden
-
Okan UniversityFethiye Cakmak Ozlu; Erol Aktunc; Ersan Ilsay KaradenizCompletedOral Hygiene | Orthodontic Appliances | Oral Health Training
Clinical Trials on ClōSYS® Unflavored Rinse
-
Rowpar Pharmaceuticals, Inc.University Health Resources GroupCompletedOral Malodor
-
Rowpar Pharmaceuticals, Inc.CompletedPeriodontitis | GingivitisUnited States
-
Sunstar AmericasCompleted
-
Medical University of South CarolinaNeilMed PharmaceuticalsCompleted
-
University of FloridaNeilMed PharmaceuticalsWithdrawnRhinosinusitis
-
University of Southern CaliforniaWallace H. Coulter Foundation; Halyard HealthCompleted
-
Johnson & Johnson Consumer and Personal Products...CompletedDentin SensitivityUnited States
-
University of North Carolina, Chapel HillColgate PalmoliveTerminatedCoronavirus Infection | COVID19 | SARS CoV-2 InfectionUnited States
-
University Fernando PessoaCompletedDental Adhesives/Restorations PerformancePortugal
-
Johnson & Johnson Consumer and Personal Products...CompletedTooth StainUnited States